Trial record 1 of 1 for:    NCT01345006
Previous Study | Return to List | Next Study

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01345006
Recruitment Status : Completed
First Posted : April 29, 2011
Last Update Posted : February 23, 2017
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Institute for Regenerative Medicine )